ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

September 7, 1990

Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol

June 14, 1991

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997